XML 22 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities      
Net income (loss) $ 28,515 $ (17,866) $ (11,811)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 6,539 6,268 3,681
Deferred income taxes (19,378) (32) 10,230
Stock-based compensation expense 7,547 9,600 10,173
Loss on disposal of property and equipment and intangibles 3 20 20
Change in fair value of earn-out liability (2,475) 11,850 (200)
Changes in assets and liabilities, net of acquisition:      
Accounts receivable 11,653 (5,348) (5,629)
Net investment in leases 1,935 (3,648) (1,774)
Inventories 597 (3,907) 972
Income taxes (721) 2,270 (2,294)
Prepaid expenses and other assets 72 (950) (1,489)
Right of use operating lease assets 71 168 614
Accounts receivable, non-current 12,125 (10,214) (3,414)
Accounts payable (3,853) 4,961 826
Accrued payroll and related taxes (311) 4,961 551
Accrued expenses and other liabilities (6,464) 7,076 2,175
Net cash provided by operating activities 35,855 5,209 2,631
Cash flows from investing activities      
Payments related to acquisition     (79,829)
Purchases of property and equipment (2,324) (1,780) (2,103)
Proceeds from sale of property and equipment   11  
Intangible assets expenditures (157) (140) (252)
Net cash used in investing activities (2,481) (1,909) (82,184)
Cash flows from financing activities      
Proceeds from issuance of note payable 8,250   30,000
Proceeds from revolving line of credit     25,000
Payment on earn-out (10,575) (5,000)  
Payments on note payable (3,000) (6,000)  
Payment on revolving line of credit (25,000)    
Payments of deferred debt issuance costs (125) (39) (188)
Taxes paid for net share settlement of performance and restricted stock units     (1,173)
Proceeds from exercise of common stock options 14 153 3,976
Proceeds from the issuance of common stock from the employee stock purchase plan 1,541 1,286 2,312
Proceeds from issuance of common stock at market 34,625    
Net cash provided by (used in) financing activities 5,730 (9,600) 59,927
Net increase (decrease) in cash and cash equivalents 39,104 (6,300) (19,626)
Cash and cash equivalents - beginning of period 21,929 28,229 47,855
Cash and cash equivalents - end of period 61,033 21,929 28,229
Supplemental cash flow disclosure      
Cash paid for interest 4,560 2,186 130
Cash paid for taxes 5,815 44 1,593
Capital expenditures incurred but not yet paid $ 528 $ 38 $ 23